ReviewTherapeutic advances in endocrinology and metabolism2014

Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Gerhard H Scholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.